Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Effects on Cardiovascular System and Exercise
NCT05232123Phase 1Withdrawn
- Sponsor
- Castleton University
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of cannabidiol (4 arms), sponsored by Castleton University. Primary endpoints: Change in heart rate variability (SDNN) at 4 weeks, Change in heart rate variability (RMSSD) at 4 weeks and 7 more. Planned start Jul 2023; status: withdrawn.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT05232123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232123.